【易明医药:子公司补缴税款 预计影响2025年净利润506.83万元】易明医药(002826.SZ)公告称,公司全资子公司维奥制药近日收到税务处理决定书,需补缴房产税及企业所得税共计452.73万元,产生滞纳金154.1万元。上述税款及滞纳金已全部缴纳完毕。其中100万元已计入公司2024年损益,剩余506.83万元将计入2025年当期损益,预计将影响公司2025年度归属于上市公司股东净利润506.83万元。

金融界
02 Jun
易明医药(002826.SZ)公告称,公司全资子公司维奥制药近日收到税务处理决定书,需补缴房产税及企业所得税共计452.73万元,产生滞纳金154.1万元。上述税款及滞纳金已全部缴纳完毕。其中100万元已计入公司2024年损益,剩余506.83万元将计入2025年当期损益,预计将影响公司2025年度归属于上市公司股东净利润506.83万元。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10